Skip to content

Who Owns the Impossible Burger? Understanding Impossible Foods' Ownership

4 min read

Founded in 2011 by former Stanford biochemistry professor Dr. Patrick Brown, Impossible Foods is the private company responsible for the popular Impossible Burger. While you might see it everywhere, the answer to who owns the Impossible Burger is more complex than a single name, involving key leadership and a roster of high-profile investors.

Quick Summary

Impossible Foods, a private food tech company founded by Patrick O. Brown, owns the Impossible Burger. It is backed by a group of diverse venture capital firms, institutional investors, and celebrities, with Peter McGuinness serving as the CEO and Brown as Chief Visionary Officer.

Key Points

  • Impossible Foods is private: The company that owns the Impossible Burger is privately held, not publicly traded on any stock exchange.

  • Founder is Patrick O. Brown: Dr. Patrick O. Brown, a former Stanford biochemist, founded Impossible Foods in 2011 with the mission to address climate change.

  • CEO is Peter McGuinness: As of April 2022, Peter McGuinness holds the CEO position, focusing on growth and innovation, while Pat Brown serves as Chief Visionary Officer.

  • Backed by major investors: The company is funded by a group of venture capital firms (e.g., Khosla Ventures, Coatue Management), institutional investors (e.g., Temasek), and high-profile individuals (e.g., Bill Gates, Jay-Z).

  • Scientific innovation is key: The Impossible Burger's unique, meat-like properties come from 'heme,' a molecule derived from genetically engineered yeast, a result of extensive scientific research.

In This Article

The Founder and The Company

The story of the Impossible Burger begins with its creator, Dr. Patrick O. Brown, a former professor at Stanford University. Driven by a mission to address the environmental impact of animal agriculture, Dr. Brown founded Impossible Foods in 2011. Instead of simply creating another veggie burger, his vision was to recreate the taste and experience of meat using plants, specifically targeting meat-eaters rather than just vegetarians. The company's scientific breakthrough involved identifying and replicating 'heme,' a molecule responsible for the distinctive flavor of meat, by fermenting genetically engineered yeast.

After years of research and development, the Impossible Burger was officially launched in 2016, first appearing on the menu at high-end restaurants in New York City. The initial strategy was to get high-profile chefs to endorse the product, which helped build buzz and establish its credibility as a quality meat alternative. This proved to be a highly successful approach, paving the way for the company's rapid expansion.

Leadership and Ownership Structure

While Patrick Brown remains the visionary force behind the company, the ownership structure is shared. In March 2022, Peter McGuinness, formerly of Chobani, was appointed as the new CEO to lead the company through its next phase of growth. Brown transitioned to the role of Chief Visionary Officer, where he continues to lead research and innovation.

As a privately-held company, Impossible Foods is not publicly traded on a stock exchange like the Nasdaq or NYSE. Its ownership is divided among a range of investors who have provided funding through various rounds. This structure allows the company to focus on long-term goals without the pressure of quarterly earnings reports that publicly-traded companies face. For prospective investors, this means the path to ownership is restricted to accredited or institutional investors through private channels or secondary marketplaces.

List of Notable Impossible Foods Investors

  • Venture Capital Firms: Khosla Ventures, Coatue Management, Google Ventures (GV), and Horizons Ventures.
  • Institutional Investors: Temasek, Mirae Asset Global Investments, UBS, and Viking Global Investors.
  • Celebrity and High-Profile Individuals: Bill Gates, Katy Perry, Serena Williams, Trevor Noah, Jaden Smith, and Jay-Z.

Funding and Expansion

Impossible Foods has attracted significant capital over the years, raising approximately $1.9 billion across multiple funding rounds. This substantial investment has fueled the company's aggressive expansion. Following its restaurant debut, the Impossible Burger expanded to grocery stores in 2019, making its plant-based products accessible to a wider consumer base. Partnerships with major food service chains like Burger King, Starbucks, and White Castle were instrumental in bringing the Impossible brand to the mainstream.

The funding has also enabled product diversification beyond the initial burger. The company has since introduced Impossible Sausage, Impossible Pork, Impossible Chicken Nuggets, and more. These expansions are all part of the founder's overarching strategy to disrupt the animal agriculture industry across different product categories.

The Path Forward: IPO on Hold?

While there have been discussions about a potential Initial Public Offering (IPO), market conditions have reportedly delayed such plans. The company last raised money at a reported $7 billion valuation in 2021, but market fluctuations and broader trends have impacted the valuation of similar companies. For now, Impossible Foods remains focused on its mission and growth as a private entity, prioritizing product innovation and market expansion.

Impossible Foods vs. Beyond Meat: A Comparison of Approach

Feature Impossible Foods Beyond Meat
Heme Molecule Uses soy leghemoglobin from genetically engineered yeast to mimic the bloody, meaty flavor and texture. Does not use heme; instead relies on a blend of other plant ingredients, like pea protein.
Target Audience Historically focused on appealing to hardcore meat-eaters, not just vegans and vegetarians. Appears to have a broader appeal but is often viewed as a more straightforward plant-based alternative.
Initial Strategy Started by placing products in high-end restaurants to build credibility. Started with retail placement, making its products readily available to consumers.
Public Status Remains a privately-held company with a diverse set of investors. Publicly traded on the Nasdaq (BYND) since 2019.
Innovation Focus Relies heavily on advanced molecular biology to replicate the sensory experience of meat. Focuses on protein blending and sourcing to create meat-like products without genetic engineering.

The Ethical and Environmental Conversation

Impossible Foods' approach has not been without controversy, particularly within certain segments of the vegan community. The use of animal testing to secure FDA approval for its heme ingredient and the utilization of a genetically engineered component have drawn criticism from some. The company has defended its actions by stating that the testing was a necessary, last-resort step for consumer safety and that the environmental benefits of its products justify its methods.

Environmentally, the company highlights its products' significantly lower footprint compared to animal-based meat. Their lifecycle analysis indicates that the Impossible Burger uses substantially less land, water, and generates fewer greenhouse gas emissions. For those concerned about sustainability, this represents a significant win. The ongoing conversations highlight the complexities and different ethical considerations within the alternative protein space.

Conclusion

In summary, the Impossible Burger is owned by the privately-held company Impossible Foods Inc., a leader in the food tech industry. Its ownership is distributed among a vast and impressive network of venture capital firms, institutional investors, and individual celebrities. Founded by scientist Patrick O. Brown to address climate change, the company has since appointed Peter McGuinness as CEO to guide its continued expansion and mission fulfillment. By leveraging scientific innovation and a strategic market approach, Impossible Foods has successfully introduced a meat alternative designed to appeal to carnivores and reduce the environmental footprint of food production.

Our Company - Impossible Foods

Frequently Asked Questions

No, Impossible Foods is a privately held company. As of late 2025, there are no immediate plans for an Initial Public Offering (IPO), and its stock is not available on public exchanges.

Impossible Foods was founded by Patrick O. Brown, a former biochemistry professor at Stanford University. He established the company in 2011 with a core mission to create a sustainable food system.

The current CEO of Impossible Foods is Peter McGuinness, who was appointed in April 2022. The company's founder, Patrick O. Brown, transitioned to the role of Chief Visionary Officer.

Impossible Foods has attracted investment from a number of notable backers, including venture capital firms like Khosla Ventures and Coatue Management, institutional funds like Temasek, and celebrities such as Bill Gates, Serena Williams, and Jay-Z.

The company used limited animal testing to obtain Generally Recognized As Safe (GRAS) status from the FDA for its soy leghemoglobin (heme) ingredient. Impossible Foods stated this was a last resort to ensure product safety and expedite its ability to combat industrial animal agriculture.

The signature meaty flavor of the Impossible Burger comes from a molecule called 'heme,' produced by fermenting genetically engineered yeast. This plant-based heme replicates the taste and sensory experience found in animal meat.

While both offer plant-based products, they differ in key areas. Impossible Foods uses genetically engineered heme for flavor, while Beyond Meat uses pea protein. Beyond Meat is publicly traded, while Impossible Foods is private. Their founding strategies and targeted consumers also differed initially.

According to the company's lifecycle analyses, its products use significantly fewer natural resources than traditional animal agriculture. For example, the Impossible Burger requires less water, land, and generates fewer greenhouse gas emissions than a beef patty from cows.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.